Latest filings (excl ownership)
8-K
MIMEDX Announces First Quarter 2024 Operating and Financial
30 Apr 24
10-Q
2024 Q1
Quarterly report
30 Apr 24
DEFA14A
Additional proxy soliciting materials
22 Apr 24
DEF 14A
Definitive proxy
22 Apr 24
8-K
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
27 Mar 24
8-K
MIMEDX Announces Appointment of Two New Independent Directors
4 Mar 24
8-K
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
28 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
MIMEDX Announces Improved Capital Structure with New Senior
22 Jan 24
8-K
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
28 Dec 23
8-K
MIMEDX to Participate in Upcoming Investor Conferences
13 Nov 23
10-Q
2023 Q3
Quarterly report
30 Oct 23
8-K
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
30 Oct 23
8-K
Departure of Directors or Certain Officers
5 Sep 23
8-K
MIMEDX to Present at Upcoming Investor Conferences
5 Sep 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
8-K
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
1 Aug 23
S-8
Registration of securities for employees
25 Jul 23
S-8
Registration of securities for employees
25 Jul 23
8-K
MIMEDX Appoints Doug Rice as Chief Financial Officer
5 Jul 23
8-K
Departure of Directors or Certain Officers
20 Jun 23
8-K
Departure of Directors or Certain Officers
14 Jun 23
DEF 14A
Definitive proxy
15 May 23
PRE 14A
Preliminary proxy
4 May 23
8-K
MIMEDX Announces First Quarter 2023 Operating and Financial Results
2 May 23
10-Q
2023 Q1
Quarterly report
2 May 23
8-K
MIMEDX Announces Chief Financial Officer Transition
24 Mar 23
S-8
Registration of securities for employees
9 Mar 23
8-K
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results
28 Feb 23
10-K
2022 FY
Annual report
28 Feb 23
8-K
Amendments to Articles of Incorporation or Bylaws
23 Feb 23
8-K
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
30 Jan 23
8-K
Results of Operations and Financial Condition
9 Jan 23
8-K
MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer
3 Jan 23
8-K
Departure of Directors or Certain Officers
16 Dec 22
8-K
Entry into a Material Definitive Agreement
8 Dec 22
8-K
Regulation FD Disclosure
30 Nov 22
8-K
Regulation FD Disclosure
17 Nov 22
8-K
MIMEDX Announces Third Quarter 2022 Operating and Financial Results
2 Nov 22
Latest ownership filings
4
William Frank IV Hulse
24 Apr 24
4
William Frank IV Hulse
10 Apr 24
3
DOROTHY E PUHY
18 Mar 24
3
Tiffany Olson
18 Mar 24
4
William Frank IV Hulse
15 Mar 24
4
William Frank IV Hulse
5 Mar 24
4
Ricci S Whitlow
5 Mar 24
4
RICE DOUG
5 Mar 24
4
Ricci S Whitlow
21 Feb 24
144
Notice of proposed sale of securities
20 Feb 24
144
Notice of proposed sale of securities
16 Feb 24
4
Ricci S Whitlow
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
144
Notice of proposed sale of securities
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
4
Change in insider ownership
27 Dec 23
SC 13D/A
Falcon Fund 2 Holding Company, L.P.
27 Dec 23
4
RICE DOUG
22 Nov 23
4
RICE DOUG
6 Jul 23
3
RICE DOUG
6 Jul 23
4
Joseph H Capper
26 Jun 23
4
JAMES L BIERMAN
15 Jun 23
4
M KATHLEEN BEHRENS
15 Jun 23
4
PHYLLIS GARDNER
15 Jun 23
4
Michael J Giuliani
15 Jun 23
4
WILLIAM A HAWKINS
15 Jun 23
4
Todd Newton
15 Jun 23
4
CATO T LAURENCIN
15 Jun 23
4
Robert Benjamin Stein
17 May 23
144
Notice of proposed sale of securities
16 May 23
144
Notice of proposed sale of securities
15 May 23
4
William Frank IV Hulse
12 May 23
4
Robert Benjamin Stein
12 May 23
4
William Lawrence Phelan
12 May 23
4
Peter M Carlson
12 May 23
144
Notice of proposed sale of securities
10 May 23
144
Notice of proposed sale of securities
10 May 23
144
Notice of proposed sale of securities
10 May 23
144
Notice of proposed sale of securities
10 May 23